AMAG Pharmaceuticals Inc. | Key People and Executives
William K. Heiden
President, Chief Executive Officer & Director
Lesley Russell
Independent Director
John A. Fallon
Independent Director
James R. Sulat
Independent Director
Barbara H. Deptula
Independent Director
Davey S. Scoon
Independent Director
Robert J. Perez
Independent Director
William K. Heiden
President, Chief Executive Officer & Director
Edward H. Myles
CFO, Treasurer, Principal Accounting Officer & SVP
Brian Robinson
Senior Vice President-Medical Affairs
Julie Krop
Chief Medical Officer & Executive Vice President
J. Alan Butcher
Chief Business Officer & Executive Vice President
Shannon Gath
Vice President
Tracy Palmer Berns
Chief Compliance Officer
Laura Williams
Senior Vice President-Clinical Development
Oscar Sanchez
Vice President-Quality
Arpad Simon
Vice President-Pharmacovigilance
Mark Stanton
Vice President-Market Access & Corporate Accounts
Nicholas Grund
Chief Commercial Officer & Executive VP
Judith Johnson
VP-Pharmacovigilance & Pharmacoepidemiology
Paul Williams
Senior Vice President-Sales & Marketing
Rushmie Nofsinger
Media Contact
Linda S. Lennox
VP-Investor Relations & Corporate Communications
Elizabeth Bolgiano
Chief Human Resources Officer & Executive VP
Joseph D. Vittiglio
Secretary, EVP-Legal Affairs & General Counsel
Helen Milton
Vice President-Regulatory Affairs
Lesley Russell
Independent Director
John A. Fallon
Independent Director
James R. Sulat
Independent Director
Barbara H. Deptula
Independent Director
Davey S. Scoon
Independent Director
Robert J. Perez
Independent Director
| Address |
1100 Winter Street
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.amagpharma.com |
| Updated |
07/08/2019 |
| AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. |
